167 related articles for article (PubMed ID: 22929559)
1. Human immunodeficiency virus and the gastrointestinal immune system: does highly active antiretroviral therapy restore gut immunity?
Costiniuk CT; Angel JB
Mucosal Immunol; 2012 Nov; 5(6):596-604. PubMed ID: 22929559
[TBL] [Abstract][Full Text] [Related]
2. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy.
Guadalupe M; Reay E; Sankaran S; Prindiville T; Flamm J; McNeil A; Dandekar S
J Virol; 2003 Nov; 77(21):11708-17. PubMed ID: 14557656
[TBL] [Abstract][Full Text] [Related]
3. Mucosal immunity in HIV infection: what can be done to restore gastrointestinal-associated lymphoid tissue function?
George MD; Asmuth DM
Curr Opin Infect Dis; 2014 Jun; 27(3):275-81. PubMed ID: 24739345
[TBL] [Abstract][Full Text] [Related]
4. Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection.
Mak G; Zaunders JJ; Bailey M; Seddiki N; Rogers G; Leong L; Phan TG; Kelleher AD; Koelsch KK; Boyd MA; Danta M
Front Immunol; 2021; 12():688886. PubMed ID: 34135912
[TBL] [Abstract][Full Text] [Related]
5. Persistent abnormalities in lymphoid tissues of human immunodeficiency virus-infected patients successfully treated with highly active antiretroviral therapy.
Schacker TW; Nguyen PL; Martinez E; Reilly C; Gatell JM; Horban A; Bakowska E; Berzins B; van Leeuwen R; Wolinsky S; Haase AT; Murphy RL
J Infect Dis; 2002 Oct; 186(8):1092-7. PubMed ID: 12355359
[TBL] [Abstract][Full Text] [Related]
6. Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection.
Guadalupe M; Sankaran S; George MD; Reay E; Verhoeven D; Shacklett BL; Flamm J; Wegelin J; Prindiville T; Dandekar S
J Virol; 2006 Aug; 80(16):8236-47. PubMed ID: 16873279
[TBL] [Abstract][Full Text] [Related]
7. The effect of timing of antiretroviral therapy on CD4+ T-cell reconstitution in the intestine of HIV-infected patients.
Allers K; Puyskens A; Epple HJ; Schürmann D; Hofmann J; Moos V; Schneider T
Mucosal Immunol; 2016 Jan; 9(1):265-74. PubMed ID: 26129649
[TBL] [Abstract][Full Text] [Related]
8. Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection.
Tincati C; Biasin M; Bandera A; Violin M; Marchetti G; Piacentini L; Vago GL; Balotta C; Moroni M; Franzetti F; Clerici M; Gori A
Antivir Ther; 2009; 14(3):321-30. PubMed ID: 19474466
[TBL] [Abstract][Full Text] [Related]
9. Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection.
Mehandru S; Poles MA; Tenner-Racz K; Jean-Pierre P; Manuelli V; Lopez P; Shet A; Low A; Mohri H; Boden D; Racz P; Markowitz M
PLoS Med; 2006 Dec; 3(12):e484. PubMed ID: 17147468
[TBL] [Abstract][Full Text] [Related]
10. Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals.
Mavigner M; Cazabat M; Dubois M; L'Faqihi FE; Requena M; Pasquier C; Klopp P; Amar J; Alric L; Barange K; Vinel JP; Marchou B; Massip P; Izopet J; Delobel P
J Clin Invest; 2012 Jan; 122(1):62-9. PubMed ID: 22156200
[TBL] [Abstract][Full Text] [Related]
11. Lymphoid tissue damage in HIV-1 infection depletes naïve T cells and limits T cell reconstitution after antiretroviral therapy.
Zeng M; Southern PJ; Reilly CS; Beilman GJ; Chipman JG; Schacker TW; Haase AT
PLoS Pathog; 2012 Jan; 8(1):e1002437. PubMed ID: 22241988
[TBL] [Abstract][Full Text] [Related]
12. A role for mucosal IL-22 production and Th22 cells in HIV-associated mucosal immunopathogenesis.
Kim CJ; Nazli A; Rojas OL; Chege D; Alidina Z; Huibner S; Mujib S; Benko E; Kovacs C; Shin LY; Grin A; Kandel G; Loutfy M; Ostrowski M; Gommerman JL; Kaushic C; Kaul R
Mucosal Immunol; 2012 Nov; 5(6):670-80. PubMed ID: 22854709
[TBL] [Abstract][Full Text] [Related]
13. Incomplete CD4 T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover.
Anthony KB; Yoder C; Metcalf JA; DerSimonian R; Orenstein JM; Stevens RA; Falloon J; Polis MA; Lane HC; Sereti I
J Acquir Immune Defic Syndr; 2003 Jun; 33(2):125-33. PubMed ID: 12794543
[TBL] [Abstract][Full Text] [Related]
14. Early antiretroviral therapy for simian immunodeficiency virus infection leads to mucosal CD4+ T-cell restoration and enhanced gene expression regulating mucosal repair and regeneration.
George MD; Reay E; Sankaran S; Dandekar S
J Virol; 2005 Mar; 79(5):2709-19. PubMed ID: 15708990
[TBL] [Abstract][Full Text] [Related]
15. Magnitude and complexity of rectal mucosa HIV-1-specific CD8+ T-cell responses during chronic infection reflect clinical status.
Critchfield JW; Young DH; Hayes TL; Braun JV; Garcia JC; Pollard RB; Shacklett BL
PLoS One; 2008; 3(10):e3577. PubMed ID: 18974782
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cells.
Al-Harthi L; Voris J; Du W; Wright D; Nowicki M; Frederick T; Landay A; Kovacs A
J Infect Dis; 2006 May; 193(9):1202-10. PubMed ID: 16586355
[TBL] [Abstract][Full Text] [Related]
17. Immune reconstitution in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy: a cohort study.
Johnston AM; Valentine ME; Ottinger J; Baydo R; Gryszowka V; Vavro C; Weinhold K; St Clair M; McKinney RE
Pediatr Infect Dis J; 2001 Oct; 20(10):941-6. PubMed ID: 11642627
[TBL] [Abstract][Full Text] [Related]
18. Impact of highly active antiretroviral therapy initiation on CD4(+) T-cell repopulation in duodenal and rectal mucosa.
Hayes TL; Asmuth DM; Critchfield JW; Knight TH; McLaughlin BE; Yotter T; McConnell DH; Garcia JC; Pollard RB; Shacklett BL
AIDS; 2013 Mar; 27(6):867-877. PubMed ID: 23262500
[TBL] [Abstract][Full Text] [Related]
19. Intestinal B cell hyperactivity in AIDS is controlled by highly active antiretroviral therapy.
Nilssen DE; Øktedalen O; Brandtzaeg P
Gut; 2004 Apr; 53(4):487-93. PubMed ID: 15016741
[TBL] [Abstract][Full Text] [Related]
20. Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphoma.
Powles T; Imami N; Nelson M; Gazzard BG; Bower M
AIDS; 2002 Mar; 16(4):531-6. PubMed ID: 11872995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
